SAVOR - SAXAGLIPTIN ASSESSMENT OF VASCULAR OUTCOMES RECORDED IN PATIENTS WITH DIABETES MELLITUS Trademark
Trademark Overview
On Monday, August 12, 2013, a trademark application was filed for SAVOR - SAXAGLIPTIN ASSESSMENT OF VASCULAR OUTCOMES RECORDED IN PATIENTS WITH DIABETES MELLITUS with the United States Patent and Trademark Office. The USPTO has given the SAVOR - SAXAGLIPTIN ASSESSMENT OF VASCULAR OUTCOMES RECORDED IN PATIENTS WITH DIABETES MELLITUS trademark a serial number of 86035910. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, July 5, 2014. This trademark is owned by Bristol-Myers Squibb Company. The SAVOR - SAXAGLIPTIN ASSESSMENT OF VASCULAR OUTCOMES RECORDED IN PATIENTS WITH DIABETES MELLITUS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use
General Information
| Serial Number | 86035910 |
| Word Mark | SAVOR - SAXAGLIPTIN ASSESSMENT OF VASCULAR OUTCOMES RECORDED IN PATIENTS WITH DIABETES MELLITUS |
| Filing Date | Monday, August 12, 2013 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Saturday, July 5, 2014 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 21, 2013 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | ASTRAZENECA AB |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 11 - Company |
| Address | SODERTALJE SE-151 85
SE |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10154 |
Trademark Events
| Event Date | Event Description |
| Wednesday, October 8, 2014 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Monday, July 7, 2014 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Saturday, July 5, 2014 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, March 19, 2014 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, March 18, 2014 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, March 18, 2014 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, November 21, 2013 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, November 21, 2013 | NON-FINAL ACTION E-MAILED |
| Thursday, November 21, 2013 | NON-FINAL ACTION WRITTEN |
| Thursday, November 14, 2013 | ASSIGNED TO EXAMINER |
| Wednesday, August 21, 2013 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, August 15, 2013 | NEW APPLICATION ENTERED IN TRAM |
